Literature DB >> 30690019

Differential Expression of Transforming Growth Factor-β1 Is Associated With Fetal Regeneration After Myocardial Infarction.

Maggie M Hodges1, Carlos Zgheib2, Junwang Xu2, Junyi Hu2, Lindel C Dewberry2, Sarah A Hilton2, Myron W Allukian3, Joseph H Gorman4, Robert C Gorman4, Kenneth W Liechty2.   

Abstract

BACKGROUND: Global extracellular matrix (ECM)-related gene expression is decreased after myocardial infarction (MI) in fetal sheep when compared with adult sheep. Transforming growth factor (TGF)-β1 is a key regulator of ECM; therefore we hypothesize that TGF-β1 is differentially expressed in adult and fetal infarcts after MI.
METHODS: Adult and fetal sheep underwent MI via ligation of the left anterior descending coronary artery. Expression of TGF-β1 and ECM-related genes was evaluated by ovine-specific microarray and quantitative polymerase chain reaction. Fibroblasts from the left ventricle of adult and fetal hearts were treated with TGF-β1 or a TGF-β1 receptor inhibitor (LY36497) to evaluate the effect of TGF-β1 on ECM-related genes.
RESULTS: Col1a1, col3a1, and MMP9 expression were increased in adult infarcts 3 and 30 days after MI but were upregulated in fetal infarcts only 3 days after MI. Three days after MI elastin expression was increased in adult infarcts. Despite upregulation in adult infarcts both 3 and 30 days after MI, TGF-β1 was not upregulated in fetal infarcts at any time point. Inhibition of the TGF-β1 receptor in adult cardiac fibroblasts decreased expression of col1a1, col3a1, MMP9, elastin, and TIMP1, whereas treatment of fetal cardiac fibroblasts with TGF-β1 increased expression of these genes.
CONCLUSIONS: TGF-β1 is increased in adult infarcts compared with regenerative, fetal infarcts after MI. Although treatment of fetal cardiac fibroblasts with TGF-β1 conveys an adult phenotype, inhibition of TGF-β1 conveys a fetal phenotype to adult cardiac fibroblasts. Decreasing TGF-β1 after MI may facilitate myocardial regeneration by "fetalizing" the otherwise fibrotic, adult response to MI.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30690019     DOI: 10.1016/j.athoracsur.2018.12.042

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

Review 1.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

2.  Inhibitory effects of formononetin on the monocrotaline‑induced pulmonary arterial hypertension in rats.

Authors:  Yonghui Wu; Changhong Cai; Lebing Yang; Yijia Xiang; Huan Zhao; Chunlai Zeng
Journal:  Mol Med Rep       Date:  2020-01-03       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.